David Castaldi from Hyland sent a memo to his distribution team about the decision to proceed with heat treating its product, on the basis not that it would eliminate hepatitis, but reduce the risk of it.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation